Further mechanistic unravelling of the influence of the cell cycle effects on the radiosensitising mechanism of vinflunine, in vitro Cindy SimoensBea PauwelsFilip Lardon Original Article 27 September 2007 Pages: 183 - 193
Tritherapy with fluorouracil/leucovorin, irinotecan and oxaliplatin (FOLFIRINOX): a phase II study in colorectal cancer patients with non-resectable liver metastases M. YchouF. ViretB. Nordlinger Original Article 28 September 2007 Pages: 195 - 201
The relative bioavailability of gefitinib administered by granular formulation Mireille V. CantariniChris J. BaileyRobert P. Smith Original Article 02 October 2007 Pages: 203 - 208
Phase II study of rubitecan in recurrent or metastatic head and neck cancer Francesco CaponigroGiacomo CartenìPatricia Pollard Original Article 19 September 2007 Pages: 209 - 214
The depletion of cellular ATP by AG2034 mediates cell death or cytostasis in a hypoxanthine-dependent manner in human prostate cancer cells Oluwakemi ObajimiPeter W. Melera Original Article 25 September 2007 Pages: 215 - 226
Effect of dalteparin and radiation on survival and thromboembolic events in glioblastoma multiforme: a phase II ECOG trial H. Ian RobinsAnne O’NeillMinesh Mehta Original Article 20 September 2007 Pages: 227 - 233
Effect of N-acetylcysteine route of administration on chemoprotection against cisplatin-induced toxicity in rat models D. Thomas DickeyLeslie L. MuldoonEdward A. Neuwelt Original Article 02 October 2007 Pages: 235 - 241
A phase I study of docetaxel with ketoconazole modulation in patients with advanced cancers Wei-Peng YongLing-Zhi WangBoon-Cher Goh Original Article 02 October 2007 Pages: 243 - 251
Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC) Fernando RiveraM. Eugenia Vega-VillegasJaime Sanz-Ortiz Original Article 28 September 2007 Pages: 253 - 261
Pemetrexed and cisplatin in patients with advanced gastric cancer: a Korean cancer study group multicenter phase II study Yeul Hong KimHyun Cheol ChungYung-Jue Bang Original Article 25 October 2007 Pages: 263 - 270
Changes of cytokines in cirrhosis patients with advanced hepatocellular carcinoma treated by intra-arterial chemotherapy Hidenari NagaiDaisuke MiyakiKazumasa Miki Original Article 26 September 2007 Pages: 271 - 276
Multicenter phase-II trial of irinotecan plus oxaliplatin [IROX regimen] in patients with poor-prognosis cancer of unknown primary: a hellenic cooperative oncology group study E. BriasoulisG. FountzilasN. Pavlidis Original Article 28 September 2007 Pages: 277 - 284
Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women ≥65 years of age Raffaele AddeoVincenzo FaiolaSalvatore Del Prete Original Article 09 October 2007 Pages: 285 - 292
Temozolomide in combination with fotemustine in patients with metastatic melanoma Faruk TasHakan CamlicaErkan Topuz Original Article 02 October 2007 Pages: 293 - 298
Irinotecan plus cisplatin and dexamethasone (ICD) combination chemotherapy for patients with diffuse large B-cell lymphoma previously treated with Rituximab plus CHOP Hye Jin KangWon Seog KimBaek-Yeol Ryoo Original Article 09 October 2007 Pages: 299 - 304
Antiproliferative effects of rapamycin as a single agent and in combination with carboplatin and paclitaxel in head and neck cancer cell lines Nasredine AissatChristophe Le TourneauSandrine Faivre Original Article 02 October 2007 Pages: 305 - 313
Extracellular signal-regulated kinase phosphorylation due to menadione-induced arylation mediates growth inhibition of pancreas cancer cells Shinji OsadaFumio SakashitaTakao Takahashi Original Article 06 October 2007 Pages: 315 - 320
Erufosine, a novel alkylphosphocholine, in acute myeloid leukemia: single activity and combination with other antileukemic drugs Michael FieglLars H. LindnerJan Braess Original Article Open access 06 October 2007 Pages: 321 - 329
Syndrome of inappropriate secretion of antidiuretic hormone after chemotherapy with vinorelbine Hiroaki KurodaMasafumi KawamuraKoichi Kobayashi Original Article 08 November 2007 Pages: 331 - 333
Syndrome of inappropriate secretion of antidiuretic hormone after chemotherapy with vinorelbine Hiroaki KurodaMasafumi KawamuraMitsuo Nakayama Erratum 11 January 2008 Pages: 335 - 335
Mechanisms of enhanced tumoricidal efficacy of multiple small dosages of ranpirnase, the novel cytotoxic ribonuclease, on lung cancer Intae LeeKuslima Shogen Original Article 05 December 2007 Pages: 337 - 346
Phase I trial of PEG-interferon and recombinant IL-2 in patients with metastatic renal cell carcinoma Saby GeorgeThomas E. HutsonRonald M. Bukowski Clinical Trial Report 02 October 2007 Pages: 347 - 354
Phase I clinical trial of intrathecal gemcitabine in patients with neoplastic meningitis Ronald J. BernardiLisa BomgaarsSusan M. Blaney Clinical Trial Report 02 October 2007 Pages: 355 - 361
Concentrations of the DNA methyltransferase inhibitor 5-fluoro-2′-deoxycytidine (FdCyd) and its cytotoxic metabolites in plasma of patients treated with FdCyd and tetrahydrouridine (THU) Jan H. BeumerRobert A. PariseMerrill J. Egorin Short Communication 26 September 2007 Pages: 363 - 368
Consumption of silibinin, a flavonolignan from milk thistle, and mammary cancer development in the C3(1) SV40 T,t antigen transgenic multiple mammary adenocarcinoma (TAg) mouse Richard D. VerschoyleKaren BrownAndreas J. Gescher Short Communication 02 October 2007 Pages: 369 - 372